Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient Perspectives on AI-Drafted Electronic Portal Messages.

JAMA network open·2026
Same author

Tracing the Pen: Electronic Health Records Amid the Rise of Generative AI.

NPJ digital medicine·2026
Same author

Comparing ambient scribes: a randomized crossover clinical trial addressing ambient scribe technologies' impact on physician burnout.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

To Achieve Zero Harm, We Must Address Financial Harm.

Journal of patient experience·2025
Same author

Déjà Vu? How Might Lessons Learned from Electronic Health Record Implementation Apply to Artificial Intelligence?

Joint Commission journal on quality and patient safety·2025
Same author

An evaluation framework for ambient digital scribing tools in clinical applications.

NPJ digital medicine·2025

Related Experiment Video

Updated: May 20, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Adverse drug events caused by serious medication administration errors.

Abhivyakti Kale1, Carol A Keohane, Saverio Maviglia

  • 1Division of General Medicine and Primary Care, Brigham & Women's Hospital, 1620 Tremont St, Boston, MA 02120, USA.

BMJ Quality & Safety
|July 14, 2012
PubMed
Summary

Serious medication errors can cause patient harm. In hospitals, approximately 4000 preventable adverse drug events (ADEs) annually stem from medication administration errors, highlighting the need for improved safety protocols.

Related Experiment Videos

Last Updated: May 20, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Area of Science:

  • Patient Safety
  • Pharmacovigilance
  • Healthcare Quality Improvement

Background:

  • Medication administration errors are frequent in hospitals.
  • The rate at which these errors cause actual harm is not well-established.
  • Serious potential adverse drug events (ADEs) require further investigation into their outcomes.

Purpose of the Study:

  • To quantify the incidence of actual harm resulting from serious or life-threatening potential adverse drug events (ADEs) during hospital medication administration.
  • To assess the severity and attribution of harm caused by medication administration errors.

Main Methods:

  • Retrospective chart review of clinical events following observed medication administration errors.
  • Analysis of 133 serious or life-threatening potential ADEs identified from a prior study of 14,041 observed medication administrations.
  • Clinical reviewers assessed ADE severity and causal attribution to the error.

Main Results:

  • Ten (7.5%) actual ADEs occurred from 133 serious potential ADEs.
  • Of these, 4 (3%) resulted in serious or life-threatening harm.
  • Dosage or monitoring errors for anti-hypertensives accounted for half of the ADEs.

Conclusions:

  • Unintercepted medication administration errors can lead to significant patient harm.
  • Hospitals administering 6 million doses annually may experience around 4000 preventable ADEs from administration errors.
  • These findings underscore the critical need for enhanced medication safety measures at the administration stage.